Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Intra-arterial Chemotherapy for Recurrent Neoplasms

Intra-arterial Chemotherapy for Recurrent Neoplasms Twenty-eight intra-arterial infusions were carried out in 25 symptomatic patients all of whom had recurrent but still regionally confined disease. Most patients had had previous surgery and/or radiation. Four of these patients died as a direct result of the treatment and ten others had complications. Four patients are still alive but have recurrences. The average survival time of the dead patients was 4 1/2 months after treatment. Although this type of treatment was occasionally helpful, few of our patients actually benefited significantly from it. Furthermore, the substantial complication rate and mortality limits its use as a palliative measure. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Intra-arterial Chemotherapy for Recurrent Neoplasms

JAMA , Volume 200 (11) – Jun 12, 1967

Loading next page...
 
/lp/american-medical-association/intra-arterial-chemotherapy-for-recurrent-neoplasms-wKWFLGFofP
Publisher
American Medical Association
Copyright
Copyright © 1967 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1967.03120240041006
Publisher site
See Article on Publisher Site

Abstract

Twenty-eight intra-arterial infusions were carried out in 25 symptomatic patients all of whom had recurrent but still regionally confined disease. Most patients had had previous surgery and/or radiation. Four of these patients died as a direct result of the treatment and ten others had complications. Four patients are still alive but have recurrences. The average survival time of the dead patients was 4 1/2 months after treatment. Although this type of treatment was occasionally helpful, few of our patients actually benefited significantly from it. Furthermore, the substantial complication rate and mortality limits its use as a palliative measure.

Journal

JAMAAmerican Medical Association

Published: Jun 12, 1967

There are no references for this article.